Back to search

Article

The construction and validation of integrated immune and metabolic gene signatures for clinical prognostic model of lung squamous cell carcinoma

2024-10-18

Abstract excerpt

<title>Abstract</title> <p>Background: Lung squamous cell carcinoma (LUSC) has a poor prognosis due to the lack of effective targeted therapies, and its incidence has dramatically increased in recent years. Therefore, new prognostic markers are urgently needed. Since tumour immune and metabolic heterogeneity can influence LUSC prognosis, systematic combinatorial analysis of immune-related and metabolism-related...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
639e8f3d-3003-50c1-96ee-2e3472b91134
DOI
10.21203/rs.3.rs-5008811/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The construction and validation of integrated immune and metabolic gene signatures for clinical prognostic model of lung squamous cell carcinomaDOI 10.21203/rs.3.rs-5008811/v1
Establishment and validation of a prognostic signature for lung squamous cell carcinoma based on metabolism‐related genesSemantic proximity
Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patientsSemantic proximity
Individualized Lipid Metabolism-Associated Six-Gene Signature for Prediction of Overall Survival, Immune Infiltration, Immunotherapy Response, and Potential Candidate Drugs in Lung Squamous Cell Carcinoma Patients: Development and ValidationSemantic proximity
Elucidating the Prognostic Biomarkers and Immune Correlations in the Co- occurrence of Chronic Obstructive Pulmonary Disease and Lung Squamous Cell CarcinomaSemantic proximity
A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma PrognosisSemantic proximity
Prediction of Prognosis, Efficacy of Lung Adenocarcinoma by Machine Learning Model Based on Immune and Metabolic Related GenesSemantic proximity
Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinomaSemantic proximity
Validation of an Immune-Related Gene Pair Index as a Prognostic Marker of Lung Squamous Cell CarcinomaSemantic proximity
Multidimensional characterization of the tumor microenvironment profiles in lung squamous cell carcinoma.Semantic proximity
A Prognostic Nomogram Combining Immune-Related Gene Signature and Clinical Factors Predicts Survival in Patients With Lung AdenocarcinomaSemantic proximity
Comprehensive Analysis of Immune-Related Metabolic Genes in Lung AdenocarcinomaSemantic proximity
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.Semantic proximity
Select a neighboring publication to make it the new centre.